PAA 2.38% 20.5¢ pharmaust limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-633

  1. 1,194 Posts.
    lightbulb Created with Sketch. 345
    EOFY sales but would expected that it will hit the CR price but don't think this will last very long. From 1 July the price appreciation will start and we should never looking back at 20C mark.

    DYOR but not a buy or sell advice. I'll be participating in SPP as this will provide better financial backup to PAA to complete phase 2/3 study without requiring a CR.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.